Full Year 2024 Results Key Financial Results Revenue: US$212.5m (up 39% from FY 2023). Net ...
H.C. Wainwright analyst Yi Chen raised the firm’s price target on LifeMD (LFMD) to $14 from $12 and keeps a Buy rating on the shares. The ...
Teladoc Health is offering fertility, digestive health, and specialty care to its enterprise customers, the company said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback